CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 77 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $17,824,767 | +58.2% | 463,945 | -4.7% | 0.02% | +50.0% |
Q1 2023 | $11,264,674 | -12.2% | 486,595 | -0.6% | 0.01% | -23.1% |
Q4 2022 | $12,830,350 | +40.6% | 489,708 | +5.5% | 0.01% | +44.4% |
Q3 2022 | $9,128,000 | +3.4% | 464,314 | -8.0% | 0.01% | 0.0% |
Q2 2022 | $8,829,000 | -33.4% | 504,825 | -37.7% | 0.01% | 0.0% |
Q1 2022 | $13,266,000 | -3.6% | 810,879 | -3.9% | 0.01% | +12.5% |
Q4 2021 | $13,762,000 | +28.8% | 843,812 | +0.7% | 0.01% | +33.3% |
Q3 2021 | $10,688,000 | -9.8% | 837,576 | -0.2% | 0.01% | 0.0% |
Q2 2021 | $11,852,000 | -9.8% | 839,380 | -0.7% | 0.01% | -14.3% |
Q1 2021 | $13,139,000 | -1.9% | 845,485 | +0.1% | 0.01% | 0.0% |
Q4 2020 | $13,397,000 | +29.2% | 844,684 | -80.2% | 0.01% | 0.0% |
Q3 2020 | $10,366,000 | – | 4,265,980 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 3,168,388 | $50,251,000 | 5.05% |
ATP Life Science Ventures, L.P. | 4,028,937 | $63,859,000 | 4.93% |
Affinity Asset Advisors, LLC | 150,000 | $2,379,000 | 1.26% |
Altium Capital Management LP | 205,799 | $3,264,000 | 1.22% |
EcoR1 Capital, LLC | 1,250,001 | $19,825,000 | 1.07% |
Vivo Capital, LLC | 1,206,266 | $19,131,000 | 0.85% |
Marquette Asset Management, LLC | 182,036 | $2,887,000 | 0.66% |
Monashee Investment Management LLC | 272,949 | $4,329,000 | 0.57% |
Ally Bridge Group (NY) LLC | 199,600 | $3,166,000 | 0.54% |
Rubric Capital Management LP | 325,863 | $5,168,000 | 0.38% |